e-learning
resources
Barcelona 2010
Monday, 20.09.2010
New mechanisms in lung development, acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tobacco smoke-induced emphysema and pulmonary hypertension – Role of NADPH oxidase NOX2
M. Seimetz, N. Parajuli, R. Schermuly, A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany)
Source:
Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Session:
New mechanisms in lung development, acute and chronic lung diseases
Session type:
E-Communication Session
Number:
2193
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Seimetz, N. Parajuli, R. Schermuly, A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany). Tobacco smoke-induced emphysema and pulmonary hypertension – Role of NADPH oxidase NOX2. Eur Respir J 2010; 36: Suppl. 54, 2193
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Role of IL-1α and IL-1β in cigarette smoke-induced pulmonary inflammation and COPD
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 804s
Year: 2006
Inhibition of NOX2 oxidase activity ameliorates cigarette smoke-induced lung inflammation and wasting in mice
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Role of lysyl oxidases in pathogenesis of pulmonary emphysema
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 276
Year: 2009
Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Phosphodiesterase inhibitors as promising therapies for cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014
Activation of membrane nadph oxidase in idiopathic pulmonary fibrosis (IPF) fibroblasts
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Viral mimetic Poly(I:C) exacerbates cigarette smoke-induced pulmonary inflammation by facilitating the release of neutrophil-derived elastase
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Role of activin-A in cigarette smoke-induced inflammation and COPD
Source: Eur Respir J 2014; 43: 1028-1041
Year: 2014
The effect of bosentan in occlusive pulmonary hypertension in rats – Role of oxidative and nitrative stress attenuation
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Role of IFNg in smoke-induced pulmonary emphysema and cachexia
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005
Lung remodeling in cigarette smoke-induced emphysema is independent of nitric oxide participation
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2003; 22: 457-461
Year: 2003
Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature
Source: Eur Respir J 2007; 30: Suppl. 51, 56s
Year: 2007
The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Role of IL-1? and the Nlrp3/caspase-1/IL-1? axis in cigarette smoke-induced pulmonary inflammation and COPD
Source: Eur Respir J 2011; 38: 1019-1028
Year: 2011
Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 84s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept